Jaguar Health (JAGX) Change in Account Payables (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Change in Account Payables of -$3.8 million for Q1 2026, down 317.93% year-over-year from $1.7 million in Q1 2025, and down 1608.03% quarter-over-quarter from $249000.0 in Q4 2025.
Jaguar Health (JAGX) Change in Account Payables (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Change in Account Payables for 13 consecutive years, with -$3.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables fell 317.93% year-over-year to -$3.8 million; the TTM figure through Mar 2026 stood at -$2.1 million (down 157.45% YoY), while the FY2025 annual figure was $3.3 million, up 920.12% from the prior year.
- Change in Account Payables fell to -$3.8 million in Q1 2026 per JAGX's latest filing, from $249000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $1.9 million in Q2 2022 and bottomed at -$3.8 million in Q1 2026.
- Historically, Change in Account Payables has averaged -$2000.0 across 5 years, with a median of $249000.0 in 2025.
- Annual changes were most pronounced in 2022 — Change in Account Payables soared 643.24% — and 2024, when it slumped 1138.81%.
- Jaguar Health's Change in Account Payables stood at -$489000.0 in 2022, then surged by 62.17% to -$185000.0 in 2023, then soared by 505.95% to $751000.0 in 2024, then slumped by 66.84% to $249000.0 in 2025, then slumped by 1608.03% to -$3.8 million in 2026.
- Business Quant data shows JAGX's Change in Account Payables at -$3.8 million in Q1 2026, $249000.0 in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn | -3.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.76 Mn |
| Mar 31, 2026 | -3.76 Mn |
| Dec 31, 2025 | 249,000.00 |
| Dec 31, 2025 | 249,000.00 |
| Sep 30, 2025 | 1.81 Mn |
| Sep 30, 2025 | 1.81 Mn |
| Jun 30, 2025 | -438,000.00 |
| Jun 30, 2025 | -438,000.00 |
| Mar 31, 2025 | 1.72 Mn |
| Mar 31, 2025 | 1.72 Mn |
| Dec 31, 2024 | 751,000.00 |
| Dec 31, 2024 | 751,000.00 |
| Sep 30, 2024 | 452,000.00 |
| Sep 30, 2024 | 452,000.00 |
| Jun 30, 2024 | 785,000.00 |
| Jun 30, 2024 | 785,000.00 |
| Mar 31, 2024 | -1.66 Mn |
| Mar 31, 2024 | -1.66 Mn |
| Dec 31, 2023 | -185,000.00 |
| Dec 31, 2023 | -185,000.00 |